封面
市場調查報告書
商品編碼
1945354

2026年全球植入式胰島素幫浦市場報告

Implantable Insulin Pump Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,植入式胰島素幫浦市場規模大幅擴大,預計將從2025年的38.8億美元成長到2026年的42.6億美元,複合年成長率達9.7%。過去幾年的成長可歸因於1型糖尿病盛行率的上升、每日多次胰島素注射的局限性、植入式胰島素幫浦技術的早期發展、人們對強化胰島素治療認知的提高以及醫院糖尿病管理實踐的改進。

預計未來幾年植入式胰島素幫浦市場規模將強勁成長,2030年將達到60.9億美元,複合年成長率(CAGR)為9.3%。預測期內的成長要素包括:自動化胰島素輸注系統的日益普及、植入式醫療設備設計的進步、對個人化糖尿病照護需求的成長、居家糖尿病管理的普及、有利的健保報銷政策以及監管支持。預測期內的主要趨勢包括:植入式胰島素輸注系統的日益普及、對閉合迴路胰島素幫浦的偏好不斷增強、透過持續胰島素輸注改善血糖控制、長期植入式糖尿病設備的接受度不斷提高,以及對患者便利性和依從性的日益重視。

糖尿病發生率的上升是植入式胰島素幫浦市場的主要促進因素。糖尿病是一種慢性疾病,患者因胰島素分泌不足或胰島素利用率降低,導致身體難以調節血糖值。糖尿病患者數量的增加與肥胖率上升、缺乏運動、不健康的飲食習慣以及人口老化密切相關。植入式胰島素幫浦能夠精準、持續地輸注胰島素,從而穩定血糖值,減少注射次數,改善糖尿病的整體管理,並提高患者的生活品質。例如,根據英國慈善機構「英國糖尿病協會」(Diabetes UK)統計,截至2024年5月,英國將有超過560萬人患有糖尿病,2022-2023年的數據顯示,與上年度相比,新增病例達167,822例。糖尿病發生率的上升正在推動植入式胰島素幫浦市場的擴張。

植入式胰島素幫浦市場的主要企業正在加強策略聯盟,以開發用於下一代植入式胰島素幫浦的高濃度、耐熱胰島素製劑。例如,2024年5月,美國生物製藥公司Arekol Therapeutics, Inc.與美國醫療技術公司Medtronic Diabetes, Inc.合作,開始利用Arekol的Arrestot技術平台開發一種新型胰島素製劑。該製劑旨在為傳統胰島素給藥方式選擇有限的患者提供幫助,並透過減少幫浦的維護、促進肝臟吸收、擴大臨床應用範圍和降低醫療成本來改善治療效果。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球植入式胰島素幫浦市場:吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧(AI)和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
  • 主要趨勢
    • 植入式胰島素輸送系統的應用日益普及
    • 人們對閉合迴路胰島素幫浦的偏好日益增強
    • 持續胰島素輸注可改善血糖控制
    • 長期植入式糖尿病設備的接受度不斷提高
    • 更加重視患者的便利性和治療依從性

第5章 終端用戶產業市場分析

  • 醫院
  • 居家醫療環境
  • 糖尿病診所
  • 門診手術中心
  • 研究和學術機構

第6章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響,以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球植入式胰島素幫浦市場:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 全球植入式胰島素幫浦市場規模、比較及成長率分析
  • 全球植入式胰島素幫浦市場表現:規模與成長,2020-2025年
  • 全球植入式胰島素幫浦市場預測:規模與成長,2025-2030年,2035年預測

第8章 全球潛在市場規模(TAM)

第9章 市場細分

  • 按類型
  • 完全植入式胰島素泵,半植入式胰島素泵
  • 透過使用
  • 1型糖尿病,第2型糖尿病
  • 最終用戶
  • 醫院、糖尿病診所、居家醫療
  • 按類型細分:完全植入式胰島素泵
  • 全自動植入式胰島素幫浦、連續血糖監測(CGM)植入式胰島素幫浦和附自適應胰島素劑量功能的植入式胰島素幫浦
  • 按類型細分:半植入式胰島素泵
  • 半自動半植入式胰島素幫浦、基礎與餐前胰島素半植入式胰島素幫浦、貼片輔助式半植入式胰島素幫浦、遙控式半植入式胰島素幫浦

第10章 區域與國家分析

  • 全球植入式胰島素幫浦市場:區域分析、預測與趨勢(2020-2025年、2025-2030年預測、2035年預測)
  • 全球植入式胰島素幫浦市場:國家、績效及預測,2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章:中國市場

第13章 印度市場

第14章 日本市場

第15章:澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章:西歐市場

第21章英國市場

第22章 德國市場

第23章:法國市場

第24章:義大利市場

第25章:西班牙市場

第26章 東歐市場

第27章:俄羅斯市場

第28章 北美市場

第29章:美國市場

第30章:加拿大市場

第31章 南美洲市場

第32章:巴西市場

第33章 中東市場

第34章:非洲市場

第35章 市場監理與投資環境

第36章:競爭格局與公司概況

  • 植入式胰島素幫浦市場:競爭格局及市場佔有率(2024年)
  • 植入式胰島素幫浦市場:公司估值矩陣
  • 植入式胰島素幫浦市場:公司概況
    • Sanofi SA
    • Abbott Laboratories
    • Medtronic plc
    • Dexcom Inc.
    • Insulet Corporation

第37章:其他領先和創新企業

  • Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra BV, Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC BV, TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章:高潛力市場國家、細分市場與策略

  • 2030年植入式胰島素幫浦市場:提供新機會的國家
  • 2030年植入式胰島素幫浦市場:充滿新機會的細分市場
  • 植入式胰島素幫浦市場2030年:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MIIPN03_G26Q1

An implantable insulin pump is a surgically placed device that delivers insulin directly into the peritoneal cavity, continuously adjusting doses according to the patient's needs to help maintain stable blood sugar levels and reduce diabetes-related complications compared to daily injections.

The main types of implantable insulin pumps include closed-loop insulin pumps and open-loop insulin pumps. Closed-loop insulin pumps, also referred to as artificial pancreas systems, are advanced devices that automatically manage blood glucose levels in individuals with diabetes. These pumps are used for applications such as type 1 diabetes and type 2 diabetes and are utilized by end users including hospitals and homecare settings.

Tariffs are impacting the implantable insulin pump market by increasing the cost of imported electronic components, sensors, and precision manufacturing equipment used in pump production. Closed-loop insulin pump systems and smart open-loop pumps are particularly impacted, with North America and Asia-Pacific regions facing higher device costs due to cross-border supply dependencies. These tariffs have contributed to elevated pricing and slower adoption in cost-sensitive markets. However, they have also encouraged local manufacturing, supply chain diversification, and innovation in cost-efficient implantable pump technologies.

The implantable insulin pump market research report is one of a series of new reports from The Business Research Company that provides implantable insulin pump market statistics, including implantable insulin pump industry global market size, regional shares, competitors with a implantable insulin pump market share, detailed implantable insulin pump market segments, market trends and opportunities, and any further data you may need to thrive in the implantable insulin pump industry. This implantable insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable insulin pump market size has grown strongly in recent years. It will grow from $3.88 billion in 2025 to $4.26 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of type 1 diabetes, limitations of multiple daily insulin injections, early development of implantable pump technology, growing awareness of intensive insulin therapy, hospital-based diabetes management practices.

The implantable insulin pump market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising adoption of automated insulin delivery systems, advancements in implantable medical device design, increasing demand for personalized diabetes care, expansion of home-based diabetes management, favorable reimbursement and regulatory support. Major trends in the forecast period include rising adoption of implantable insulin delivery systems, growing preference for closed-loop insulin pumps, improved glycemic control through continuous insulin infusion, increasing acceptance of long-term implantable diabetes devices, enhanced focus on patient convenience and therapy adherence.

The rise in diabetes incidence is increasingly supporting the expansion of the implantable insulin pump market going forward. Diabetes is a chronic condition in which the body struggles to regulate blood glucose levels due to insufficient insulin production or ineffective insulin utilization. The growing number of diabetes cases is linked to rising obesity rates, physical inactivity, unhealthy dietary habits, and aging populations. Implantable insulin pumps provide precise and continuous insulin delivery, helping stabilize blood glucose levels, reduce the frequency of injections, and improve overall diabetes management and patient quality of life. For example, in May 2024, according to Diabetes UK, a UK-based charity, more than 5.6 million people were living with diabetes in the UK, with 2022-23 figures showing an increase of 167,822 cases compared to the previous year. Consequently, the rising incidence of diabetes is reinforcing expansion within the implantable insulin pump market.

Leading companies in the implantable insulin pump market are increasingly forming strategic partnerships to develop high-concentration, thermostable insulin formulations for next-generation implantable pumps. For example, in May 2024, Arecor Therapeutics plc, a US-based biopharmaceutical company, partnered with Medtronic Diabetes, a US-based medical technology company, to develop a novel insulin formulation using Arecor's Arestat technology platform. This formulation is designed for patients with limited options under conventional insulin delivery and aims to improve outcomes by reducing pump maintenance, enabling hepatic absorption, expanding clinical use, and lowering healthcare costs.

In June 2024, Arecor Therapeutics plc, a UK-based biotechnology company, partnered with Medtronic plc to develop a high-concentration, thermostable insulin for Medtronic's advanced implantable insulin pump systems. This collaboration seeks to improve treatment options for diabetes patients requiring intensive insulin therapy. Medtronic plc is an Ireland-based manufacturer of implantable insulin pumps.

Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.

North America was the largest region in the implantable insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable insulin pump market consists of sales of pump devices, delivery catheters, control systems, and insulin reservoirs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Insulin Pump Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses implantable insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable insulin pump market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Fully Implantable Insulin Pump; Semi-Implantable Insulin Pump
  • 2) By Application: Type 1 Diabetes; Type 2 Diabetes
  • 3) By End-User: Hospitals; Diabetes Clinics; Home-Care
  • Subsegments:
  • 1) By Fully Implantable Insulin Pump: Fully Automated Implantable Insulin Pump; Implantable Insulin Pump with Continuous Glucose Monitoring (CGM); Implantable Insulin Pump with Adaptive Insulin Delivery
  • 2) By Semi-Implantable Insulin Pump: Semi-Automated Semi-Implantable Insulin Pump; Basal-Bolus Semi-Implantable Insulin Pump; Patch-Assisted Semi-Implantable Insulin Pump; Remote-Controlled Semi-Implantable Insulin Pump
  • Companies Mentioned: Sanofi S.A.; Abbott Laboratories; Medtronic plc; Dexcom Inc.; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Air Liquide Healthcare Ltd.; Diabeloop SA; Glooko Inc.; ViCentra B.V.; Bigfoot Biomedical Inc.; Beta Bionics Inc.; Senseonics Holdings Inc.; INREDA DIABETIC B.V.; TIDEPOOL Inc.; Medtrum Technologies Inc.; Sernova Corp.; PhysioLogic Devices Inc.; EOFLOW CO. LTD.; CamDiab Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Implantable Insulin Pump Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Implantable Insulin Pump Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Implantable Insulin Pump Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Implantable Insulin Pump Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Implantable Insulin Delivery Systems
    • 4.2.2 Growing Preference For Closed-Loop Insulin Pumps
    • 4.2.3 Improved Glycemic Control Through Continuous Insulin Infusion
    • 4.2.4 Increasing Acceptance Of Long-Term Implantable Diabetes Devices
    • 4.2.5 Enhanced Focus On Patient Convenience And Therapy Adherence

5. Implantable Insulin Pump Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home-Care Settings
  • 5.3 Diabetes Specialty Clinics
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Research And Academic Institutes

6. Implantable Insulin Pump Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Implantable Insulin Pump Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Implantable Insulin Pump PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Implantable Insulin Pump Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Implantable Insulin Pump Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Implantable Insulin Pump Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Implantable Insulin Pump Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Implantable Insulin Pump Market Segmentation

  • 9.1. Global Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fully Implantable Insulin Pump, Semi-Implantable Insulin Pump
  • 9.2. Global Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Type 1 Diabetes, Type 2 Diabetes
  • 9.3. Global Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diabetes Clinics, Home-Care
  • 9.4. Global Implantable Insulin Pump Market, Sub-Segmentation Of Fully Implantable Insulin Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fully Automated Implantable Insulin Pump, Implantable Insulin Pump with Continuous Glucose Monitoring (CGM), Implantable Insulin Pump with Adaptive Insulin Delivery
  • 9.5. Global Implantable Insulin Pump Market, Sub-Segmentation Of Semi-Implantable Insulin Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Semi-Automated Semi-Implantable Insulin Pump, Basal-Bolus Semi-Implantable Insulin Pump, Patch-Assisted Semi-Implantable Insulin Pump, Remote-Controlled Semi-Implantable Insulin Pump

10. Implantable Insulin Pump Market Regional And Country Analysis

  • 10.1. Global Implantable Insulin Pump Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Implantable Insulin Pump Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Implantable Insulin Pump Market

  • 11.1. Asia-Pacific Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Implantable Insulin Pump Market

  • 12.1. China Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Implantable Insulin Pump Market

  • 13.1. India Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Implantable Insulin Pump Market

  • 14.1. Japan Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Implantable Insulin Pump Market

  • 15.1. Australia Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Implantable Insulin Pump Market

  • 16.1. Indonesia Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Implantable Insulin Pump Market

  • 17.1. South Korea Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Implantable Insulin Pump Market

  • 18.1. Taiwan Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Implantable Insulin Pump Market

  • 19.1. South East Asia Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Implantable Insulin Pump Market

  • 20.1. Western Europe Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Implantable Insulin Pump Market

  • 21.1. UK Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Implantable Insulin Pump Market

  • 22.1. Germany Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Implantable Insulin Pump Market

  • 23.1. France Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Implantable Insulin Pump Market

  • 24.1. Italy Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Implantable Insulin Pump Market

  • 25.1. Spain Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Implantable Insulin Pump Market

  • 26.1. Eastern Europe Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Implantable Insulin Pump Market

  • 27.1. Russia Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Implantable Insulin Pump Market

  • 28.1. North America Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Implantable Insulin Pump Market

  • 29.1. USA Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Implantable Insulin Pump Market

  • 30.1. Canada Implantable Insulin Pump Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Implantable Insulin Pump Market

  • 31.1. South America Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Implantable Insulin Pump Market

  • 32.1. Brazil Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Implantable Insulin Pump Market

  • 33.1. Middle East Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Implantable Insulin Pump Market

  • 34.1. Africa Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Implantable Insulin Pump Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Implantable Insulin Pump Market Regulatory and Investment Landscape

36. Implantable Insulin Pump Market Competitive Landscape And Company Profiles

  • 36.1. Implantable Insulin Pump Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Implantable Insulin Pump Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Implantable Insulin Pump Market Company Profiles
    • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Implantable Insulin Pump Market Other Major And Innovative Companies

  • Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD.

38. Global Implantable Insulin Pump Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Implantable Insulin Pump Market

40. Implantable Insulin Pump Market High Potential Countries, Segments and Strategies

  • 40.1 Implantable Insulin Pump Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Implantable Insulin Pump Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Implantable Insulin Pump Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer